Publications
- Année de publication : 2015-04-22
Référence
G. Chevrier, P.L. Mitchell, L-E Rioux, F. Hasan, T. Jin, C. Roblet, A. Doyen, G. Pilon, P. St-Pierre, C. Lavigne, L. Bazinet, H. Jacques, T. Gill, R. S McLeod, A. Marette. 2015. Low-molecular-Weight Peptides from salmon protein prevent obesity-linked glucose intolerance, inflammation and dyslipidemia in LDLR-/-/ApoB100/100 Mice. The Journal of Nutrition, doi:10.3945/jn.114.208215.
Information Complémentaire
Lien vers l'article : https://academic.oup.com/jn/article/145/7/1415/4644389
Mot(s) Clé(s)
Peptides Oméga-3 Métabolisme du glucose Insuline Anti-inflammatoire Hydrolysat protéique Acides aminés
Résumé
We previously reported that fish proteins can alleviate metabolic syndrome (MetS) in obese animals and human subjects. We tested whether a salmon peptide fraction (SPF) could improve MetS in mice and explored potential mechanisms of action. ApoB100 only, LDL receptor knockout male mice (LDLR−/−/ApoB100/100) were fed a high-fat and -sucrose (HFS) diet (25 g/kg sucrose). Two groups were fed 10 g/kg casein hydrolysate (HFS), and 1 group was additionally fed 4.35 g/kg fish oil (FO; HFS+FO). Two other groups were fed 10 g SPF/kg (HFS+SPF), and 1 group was additionally fed 4.35 g FO/kg (HFS+SPF+FO). A fifth (reference) group was fed a standard feed pellet diet. We assessed the impact of dietary treatments on glucose tolerance, adipose tissue inflammation, lipid homeostasis, and hepatic insulin signaling. The effects of SPF on glucose uptake, hepatic glucose production, and inducible nitric oxide synthase activity were further studied in vitro with the use of L6 myocytes, FAO hepatocytes, and J774 macrophages. Mice fed HFS+SPF or HFS+SPF+FO diets had lower body weight (protein effect, P = 0.024), feed efficiency (protein effect, P = 0.018), and liver weight (protein effect, P = 0.003) as well as lower concentrations of adipose tissue cytokines and chemokines (protein effect, P ≤ 0.003) compared with HFS and HFS+FO groups. They also had greater glucose tolerance (protein effect, P < 0.001), lower activation of the mammalian target of rapamycin complex 1/S6 kinase 1/insulin receptor substrate 1 (mTORC1/S6K1/IRS1) pathway, and increased insulin signaling in liver compared with the HFS and HFS+FO groups. The HFS+FO, HFS+SPF, and HFS+SPF+FO groups had lower plasma triglycerides (protein effect, P = 0.003; lipid effect, P = 0.002) than did the HFS group. SPF increased glucose uptake and decreased HGP and iNOS activation in vitro. SPF reduces obesity-linked MetS features in LDLR−/−/ApoB100/100 mice. The anti-inflammatory and glucoregulatory properties of SPF were confirmed in L6 myocytes, FAO hepatocytes, and J774 macrophages.
